Mitchell Arvette E, Patel Arpit P, DiCandilo Jennifer, Rebollido Zachary W, Pettengill Matthew A
Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Department of Pharmacy, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Access Microbiol. 2025 Jun 3;7(6). doi: 10.1099/acmi.0.000918.v4. eCollection 2025.
Methicillin-resistant (MRSA) causes considerable morbidity and mortality in both community-acquired and healthcare-associated infections, but detecting colonization with MRSA has been shown to improve patient outcomes in certain clinical settings. MRSA colonization detection has been carried out in a variety of ways, with molecular assays having superior sensitivity in most studies relative to culture, but culture is disadvantaged in some comparisons by utilization of low specimen volumes. We compared a commercial molecular assay to both low-volume (10 µl) and high-volume (650 µl) cultures and found that increasing the volume utilized for culture led to the detection of 25% more cases than low-volume culture.
耐甲氧西林金黄色葡萄球菌(MRSA)在社区获得性感染和医疗保健相关感染中均会导致相当高的发病率和死亡率,但已证明在某些临床环境中检测MRSA定植可改善患者预后。MRSA定植检测已通过多种方式进行,在大多数研究中,分子检测相对于培养具有更高的灵敏度,但在一些比较中,由于使用的样本量较少,培养处于劣势。我们将一种商业分子检测方法与低样本量(10微升)和高样本量(650微升)培养方法进行了比较,发现增加培养所用的样本量比低样本量培养多检测出25%的病例。